Phalangeal Fracture During Attempted Dupuytrens Release Following Clostridial Collagenase Injection: Case Report

摘要

Introduction:Dupuytren’s disease can be a challenging condition for both patients and surgeons. Injectable collagen clostridium histolyticum was approved for clinical use by the Food and Drug Administration in 2010. A number of side effects have been described. In this case report, we present a complication of a proximal phalanx fracture which occurred during attempted release post injection. To the best of our knowledge, this is the first reported case of this particular complication.